BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 31809227)

  • 1. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
    Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
    Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphane suppresses skin squamous cell carcinoma cells proliferation through miR-199a-5p/Sirt1/CD44ICD signaling pathway.
    Zhang Y; Ai P; Chen SZ; Lei SY
    Immunopharmacol Immunotoxicol; 2023 Feb; 45(1):52-60. PubMed ID: 35947042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
    Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
    Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma.
    Chen J; Hou SF; Tang FJ; Liu DS; Chen ZZ; Zhang HL; Wang SH
    Oncogene; 2022 Jan; 41(1):99-111. PubMed ID: 34697449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
    Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
    Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-142-5p induces cancer stem cell-like properties of cutaneous squamous cell carcinoma via inhibiting PTEN.
    Bai X; Zhou Y; Chen P; Yang M; Xu J
    J Cell Biochem; 2018 Feb; 119(2):2179-2188. PubMed ID: 28857248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.
    Cheng W; Liu T; Wan X; Gao Y; Wang H
    FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of miR-199a-5p target genes in the skin keratinocyte and their expression in cutaneous squamous cell carcinoma.
    Kim BK; Kim I; Yoon SK
    J Dermatol Sci; 2015 Aug; 79(2):137-47. PubMed ID: 26026896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
    Wang R; Dong HX; Zeng J; Pan J; Jin XY
    J Cell Physiol; 2018 Sep; 233(9):7447-7456. PubMed ID: 29663359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-methylation-mediated silencing of miR-7-5p promotes gastric cancer stem cell invasion via increasing Smo and Hes1.
    Xin L; Liu L; Liu C; Zhou LQ; Zhou Q; Yuan YW; Li SH; Zhang HT
    J Cell Physiol; 2020 Mar; 235(3):2643-2654. PubMed ID: 31517391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
    Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
    Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis.
    Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G; Wang K
    J Cell Physiol; 2019 Nov; 234(11):20816-20828. PubMed ID: 31012108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-98-5p inhibits gastric cancer cell stemness and chemoresistance by targeting branched-chain aminotransferases 1.
    Zhan P; Shu X; Chen M; Sun L; Yu L; Liu J; Sun L; Yang Z; Ran Y
    Life Sci; 2021 Jul; 276():119405. PubMed ID: 33798550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
    Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
    Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.
    Bourguignon LY; Earle C; Wong G; Spevak CC; Krueger K
    Oncogene; 2012 Jan; 31(2):149-60. PubMed ID: 21685938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
    Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
    J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
    Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
    J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
    Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
    Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.